November 18th, 2009
Bureau Of Transportation | One more mouth to feed.5 comments
November 11th, 2009
Washington Co. DA’s Office | Abusing a domestic violence law.25 comments
November 4th, 2009
University Of Oregon | Who’s killing Rudolph?7 comments
October 28th, 2009
Metro | A blowhard answer to global warming? 6 comments
October 21st, 2009
Michael Ruppert | Peak trouble for an Oregon author.23 comments
October 7th, 2009
Beaverton Police | Zero tolerance for video recorders.11 comments
September 30th, 2009
Lynn Peterson | C’mon, Dems. Are Kitzhaber and Bradbury that formidable?3 comments
September 23rd, 2009
Denny Doyle | Beaverton mayor hits a foul ball.3 comments
September 2nd, 2009
Oregon Bankers Association | For bailouts, then against them.6 comments
August 19th, 2009
Wal-Mart | Save money. Live worse.9 comments
![]() |
[March 1st, 2006] Big Pharma certainly is entitled to profit from others' ills. But this week's Rogue takes that to an absurd extreme with its shameless attempt at cashing in on meth-related hysteria.
New York-based Hogil Pharmaceutical Corporation pitches Sine-Off, a brand of over-the-counter cough and sinus medication available locally at Fred Meyer, Kmart and other stores.
You may have heard the spots on Portland radio that claim the medicine tackles sneezing, fever, housefires and vandalism. The product website (www.sineoff.com) boasts how Sine-Off "works to fight colds, flus, sinus congestion and the devastating effects of Meth abuse."
No, Sine-Off won't help a meth-head kick the habit. What it does is deprive addicts of one product that's been used to make their drug of choice, because Sine-Off was reformulated last year. It now uses phenylephrine as its active ingredient in lieu of the meth-precursor pseudoephedrine. Is the move sheer corporate altruism, as Hogil might have us believe?
"We're not about cashing in on anyone's misfortune," says Hogil spokesman Sean Evans. And to Hogil's credit, it has donated some money to the nonprofit Partnership for a Drug-Free America (Evans declined to specify the amount).
But suggesting the company didn't have one eye squarely on the bottom line when it made the switch—and started an ad campaign that says Sine-Off fights meth abuse—is BS. Oregon and more than 35 other states have severely restricted the sale of medications containing pseudoephedrine. Similar federal laws are in the works. A switch to phenylephrine therefore means more sales, which Hogil isn't the only drug company to realize. Pfizer already has a phenylephrine-based Sudafed on the market, while brands from Vicks to Alka-Seltzer are also releasing pseudoephedrine-free products. The only thing unique about Sine-Off is that the entire line is pseudoephedrine-free, while other brands still make some products using the ingredient.
But if a lack of pseudoephedrine makes something "anti-meth," WW has those suckers beat: We've been pseudoephedrine-free since 1974. No reformulations necessary.
RECENT COMMENTS ON “Hogil Pharmaceutical Corporation”
Hogil Pharmaceutical CorporationUsually I agree with a lot of the rogues, but I didnt agree with this one.—mick
Hogil Pharmaceutical CorporationI am sorry....but not one pharm company made anyone make meth....its all about choices you make and the consequences of them!—Mike
Hogil Pharmaceutical CorporationCome on people . . . Portland's nooks and crannies are sure to turn up plenty a rogues. Corporations are always already in rogue status by the very nature of th...
Hogil Pharmaceutical CorporationWW is way off base. This company is doing a good thing. Even if they are advertising it cynically. Is this really the best example of a rogue that you can find...












